Savant Capital LLC raised its stake in Haleon PLC Sponsored ADR (NYSE:HLN – Free Report) by 249.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 113,228 shares of the company’s stock after purchasing an additional 80,831 shares during the period. Savant Capital LLC’s holdings in Haleon were worth $1,145,000 as of its most recent filing with the Securities and Exchange Commission (SEC).
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Atlantic Union Bankshares Corp grew its stake in shares of Haleon by 293.7% during the third quarter. Atlantic Union Bankshares Corp now owns 3,697 shares of the company’s stock worth $33,000 after acquiring an additional 2,758 shares during the last quarter. Stance Capital LLC purchased a new stake in shares of Haleon during the third quarter worth about $34,000. Geneos Wealth Management Inc. grew its stake in shares of Haleon by 33.0% during the first quarter. Geneos Wealth Management Inc. now owns 4,846 shares of the company’s stock worth $50,000 after acquiring an additional 1,203 shares during the last quarter. Caitong International Asset Management Co. Ltd grew its stake in shares of Haleon by 428.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 6,321 shares of the company’s stock worth $57,000 after acquiring an additional 5,124 shares during the last quarter. Finally, Assetmark Inc. grew its stake in shares of Haleon by 26.6% during the fourth quarter. Assetmark Inc. now owns 5,962 shares of the company’s stock worth $60,000 after acquiring an additional 1,252 shares during the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.
Haleon Trading Down 2.6%
Shares of NYSE:HLN opened at $8.83 on Tuesday. Haleon PLC Sponsored ADR has a 12-month low of $8.71 and a 12-month high of $11.42. The company has a market capitalization of $39.09 billion, a PE ratio of 22.63, a PEG ratio of 2.06 and a beta of 0.13. The business has a 50 day moving average of $9.51 and a two-hundred day moving average of $9.95. The company has a current ratio of 0.92, a quick ratio of 0.71 and a debt-to-equity ratio of 0.47.
Wall Street Analysts Forecast Growth
A number of equities research analysts have recently weighed in on HLN shares. Wall Street Zen upgraded Haleon from a “hold” rating to a “buy” rating in a research note on Saturday, March 21st. Argus upgraded Haleon to a “strong-buy” rating in a research report on Tuesday, March 17th. Finally, Deutsche Bank Aktiengesellschaft reiterated a “sell” rating on shares of Haleon in a research report on Thursday, April 30th. Two investment analysts have rated the stock with a Strong Buy rating, three have given a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy”.
Get Our Latest Analysis on Haleon
Haleon Company Profile
Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.
The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.
Further Reading
- Five stocks we like better than Haleon
- Why These Three Big Buybacks Are Sending Very Different Signals to Investors
- Drone Stocks Soar As Pentagon Considers Funding, Including a Trump-Linked Name
- Braze Blazes Ahead on Q1 2027 Earnings Beat, Raised Guidance
- Are the 3 Newest Members of the $1 Trillion Market Cap Club the Latest Sign of an AI Bubble?
Want to see what other hedge funds are holding HLN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Haleon PLC Sponsored ADR (NYSE:HLN – Free Report).
Receive News & Ratings for Haleon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Haleon and related companies with MarketBeat.com's FREE daily email newsletter.
